Germans Trias researchers lead an international clinical trial to halt the advance of multiple sclerosis using cell therapy
A team of researchers from the Germans Trias i Pujol Hospital and Institute on the Can Ruti Campus, have started a phase I trial to slow the progress of multiple sclerosis (MS) with a cell product that uses the patient's own cells and reprograms their immune system.
![](/media/upload/gif/20180917-restore_153717023358.jpg)